IMMUNO-METABOLIC SIGNATURES OF DENDRITIC CELLS ASSOCIATE WITH T-CELL RESPONSES IN MELANOMA PATIENTS - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2020

IMMUNO-METABOLIC SIGNATURES OF DENDRITIC CELLS ASSOCIATE WITH T-CELL RESPONSES IN MELANOMA PATIENTS

Résumé

The therapeutic efficacy of Dendritic cells (DC) vaccines remains low and there is an unmet need for more effective vaccine design to achieve durable clinical outcomes. Our study analyzed the transcriptomic and energetic metabolism profile of an adenoviral-based DC vaccine targeted against three commonly shared melanoma antigens: Tyrosinase, MART-1 and MAGE-A6 from 35 subjects enrolled in a Phase I study of autologous DC vaccines in late-stage melanoma.1 To further investigate the immuno-metabolic features of monocyte- derived DC vaccines, we are employing a novel flow cytometry-based method, called SCENITH2 to integrate functional metabolic states with multiparametric DC immune phenotypes.
Fichier principal
Vignette du fichier
Adamik Juraj SITC cancer.pdf (57.25 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03451694 , version 1 (26-11-2021)

Licence

Identifiants

Citer

Juraj Adamik, Deena Maurer, Paul Munson, Alexis Combes, Philippe Pierre, et al.. IMMUNO-METABOLIC SIGNATURES OF DENDRITIC CELLS ASSOCIATE WITH T-CELL RESPONSES IN MELANOMA PATIENTS. SICT, Nov 2020, Los Angeles, United States. pp.A325 - A325, ⟨10.1136/jitc-2020-sitc2020.0299⟩. ⟨hal-03451694⟩
39 Consultations
39 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More